- Home
- ANIX vs CNVS Comparison
ANIX vs CNVS Comparison
Compare ANIX & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- CNVS
- Stock Information
- Founded
- ANIX 1982
- CNVS 2000
- Country
- ANIX United States
- CNVS United States
- Employees
- ANIX N/A
- CNVS N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- CNVS Consumer Electronics/Video Chains
- Sector
- ANIX Health Care
- CNVS Consumer Discretionary
- Exchange
- ANIX Nasdaq
- CNVS Nasdaq
- Market Cap
- ANIX 95.7M
- CNVS 102.4M
- IPO Year
- ANIX 1987
- CNVS 2003
- Fundamental
- Price
- ANIX $3.35
- CNVS $3.27
- Analyst Decision
- ANIX Strong Buy
- CNVS Buy
- Analyst Count
- ANIX 3
- CNVS 1
- Target Price
- ANIX $9.00
- CNVS $10.00
- AVG Volume (30 Days)
- ANIX 108.8K
- CNVS 383.1K
- Earning Date
- ANIX 09-10-2025
- CNVS 11-13-2025
- Dividend Yield
- ANIX N/A
- CNVS N/A
- EPS Growth
- ANIX N/A
- CNVS N/A
- EPS
- ANIX N/A
- CNVS 0.13
- Revenue
- ANIX N/A
- CNVS $80,173,000.00
- Revenue This Year
- ANIX N/A
- CNVS $1.28
- Revenue Next Year
- ANIX N/A
- CNVS N/A
- P/E Ratio
- ANIX N/A
- CNVS $24.78
- Revenue Growth
- ANIX N/A
- CNVS 77.07
- 52 Week Low
- ANIX $2.07
- CNVS $0.79
- 52 Week High
- ANIX $4.20
- CNVS $7.39
- Technical
- Relative Strength Index (RSI)
- ANIX 59.63
- CNVS 28.84
- Support Level
- ANIX $2.93
- CNVS $3.29
- Resistance Level
- ANIX $3.09
- CNVS $3.91
- Average True Range (ATR)
- ANIX 0.16
- CNVS 0.26
- MACD
- ANIX 0.06
- CNVS -0.06
- Stochastic Oscillator
- ANIX 62.69
- CNVS 3.27
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.